Thursday, October 23, 2014

Eli Lilly's Sales Hit Again by Patent Expirations

Eli Lilly said its sales and profit fell in the most recent period, reflecting patent expirations and generic competition.



from WSJ.com: US Business http://ift.tt/1sST4CO

via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)